277 related articles for article (PubMed ID: 23052388)
21. Critical role for cross-linking of trimeric lectin domains of surfactant protein D in antiviral activity against influenza A virus.
Tecle T; White MR; Sorensen G; Gantz D; Kacak N; Holmskov U; Smith K; Crouch EC; Hartshorn KL
Biochem J; 2008 Jun; 412(2):323-9. PubMed ID: 18302538
[TBL] [Abstract][Full Text] [Related]
22. Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity.
Al-Qahtani AA; Murugaiah V; Bashir HA; Pathan AA; Abozaid SM; Makarov E; Nal-Rogier B; Kishore U; Al-Ahdal MN
Immunobiology; 2019 May; 224(3):408-418. PubMed ID: 30954271
[TBL] [Abstract][Full Text] [Related]
23. Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis.
Tripathi S; Wang G; White M; Rynkiewicz M; Seaton B; Hartshorn K
PLoS One; 2015; 10(8):e0133454. PubMed ID: 26308522
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain.
White MR; Boland P; Tecle T; Gantz D; Sorenson G; Tornoe I; Holmskov U; McDonald B; Crouch EC; Hartshorn KL
J Innate Immun; 2010; 2(3):267-79. PubMed ID: 20375547
[TBL] [Abstract][Full Text] [Related]
25. Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.
Doss M; Ruchala P; Tecle T; Gantz D; Verma A; Hartshorn A; Crouch EC; Luong H; Micewicz ED; Lehrer RI; Hartshorn KL
J Immunol; 2012 Mar; 188(6):2759-68. PubMed ID: 22345650
[TBL] [Abstract][Full Text] [Related]
26. Multiple components contribute to ability of saliva to inhibit influenza viruses.
White MR; Helmerhorst EJ; Ligtenberg A; Karpel M; Tecle T; Siqueira WL; Oppenheim FG; Hartshorn KL
Oral Microbiol Immunol; 2009 Feb; 24(1):18-24. PubMed ID: 19121065
[TBL] [Abstract][Full Text] [Related]
27. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes.
White MR; Kandel R; Tripathi S; Condon D; Qi L; Taubenberger J; Hartshorn KL
PLoS One; 2014; 9(7):e101364. PubMed ID: 24988208
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of influenza viral neuraminidase activity by collectins.
Tecle T; White MR; Crouch EC; Hartshorn KL
Arch Virol; 2007; 152(9):1731-42. PubMed ID: 17514488
[TBL] [Abstract][Full Text] [Related]
30. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.
Verma A; White M; Vathipadiekal V; Tripathi S; Mbianda J; Ieong M; Qi L; Taubenberger JK; Takahashi K; Jensenius JC; Thiel S; Hartshorn KL
J Immunol; 2012 Sep; 189(5):2478-87. PubMed ID: 22851708
[TBL] [Abstract][Full Text] [Related]
31. Porcine pulmonary collectins show distinct interactions with influenza A viruses: role of the N-linked oligosaccharides in the carbohydrate recognition domain.
van Eijk M; White MR; Crouch EC; Batenburg JJ; Vaandrager AB; Van Golde LM; Haagsman HP; Hartshorn KL
J Immunol; 2003 Aug; 171(3):1431-40. PubMed ID: 12874235
[TBL] [Abstract][Full Text] [Related]
32. Influenza Virus Hemagglutinins H2, H5, H6, and H11 Are Not Targets of Pulmonary Surfactant Protein D:
Parsons LM; An Y; Qi L; White MR; van der Woude R; Hartshorn KL; Taubenberger JK; de Vries RP; Cipollo JF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826991
[TBL] [Abstract][Full Text] [Related]
33. Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus.
White M; Kingma P; Tecle T; Kacak N; Linders B; Heuser J; Crouch E; Hartshorn K
J Immunol; 2008 Dec; 181(11):7936-43. PubMed ID: 19017984
[TBL] [Abstract][Full Text] [Related]
34. Impact of neutrophils on antiviral activity of human bronchoalveolar lavage fluid.
White MR; Tecle T; Crouch EC; Hartshorn KL
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1293-9. PubMed ID: 17720872
[TBL] [Abstract][Full Text] [Related]
35. Increasing antiviral activity of surfactant protein d trimers by introducing residues from bovine serum collectins: dissociation of mannan-binding and antiviral activity.
Hartshorn KL; White MR; Smith K; Sorensen G; Kuroki Y; Holmskov U; Head J; Crouch EC
Scand J Immunol; 2010 Jul; 72(1):22-30. PubMed ID: 20591072
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.
LeMessurier KS; Lin Y; McCullers JA; Samarasinghe AE
Antiviral Res; 2016 Sep; 133():208-17. PubMed ID: 27531368
[TBL] [Abstract][Full Text] [Related]
37. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
[TBL] [Abstract][Full Text] [Related]
38. Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
Barlow PG; Svoboda P; Mackellar A; Nash AA; York IA; Pohl J; Davidson DJ; Donis RO
PLoS One; 2011; 6(10):e25333. PubMed ID: 22031815
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Antiviral Activity of Human Surfactant Protein D by Site-Specific Engineering of the Carbohydrate Recognition Domain.
van Eijk M; Hillaire MLB; Rimmelzwaan GF; Rynkiewicz MJ; White MR; Hartshorn KL; Hessing M; Koolmees PA; Tersteeg MH; van Es MH; Meijerhof T; Huckriede A; Haagsman HP
Front Immunol; 2019; 10():2476. PubMed ID: 31749796
[TBL] [Abstract][Full Text] [Related]
40. Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.
Job ER; Bottazzi B; Gilbertson B; Edenborough KM; Brown LE; Mantovani A; Brooks AG; Reading PC
PLoS One; 2013; 8(3):e59623. PubMed ID: 23544079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
